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Infrared spectroscopyThe plasma membrane–cytoskeleton interface is a dynamic structure participating in a variety of cellular
events. Moesin and ezrin, proteins from the ezrin/radixin/moesin (ERM) family, provide a direct linkage be-
tween the cytoskeleton and the membrane via their interaction with phosphatidylinositol 4,5-bisphosphate
(PIP2). PIP2 binding is considered as a prerequisite step in ERM activation. The main objective of this work
was to compare moesin and ezrin interaction with PIP2-containing membranes in terms of afﬁnity and to an-
alyze secondary structure modiﬁcations leading eventually to ERM activation. For this purpose, we used two
types of biomimetic model membranes, large and giant unilamellar vesicles. The dissociation constant be-
tween moesin and PIP2-containing large unilamellar vesicles or PIP2-containing giant unilamellar vesicles
was found to be very similar to that between ezrin and PIP2-containing large unilamellar vesicles or PIP2-
containing giant unilamellar vesicles. In addition, both proteins were found to undergo conformational
changes after binding to PIP2-containing large unilamellar vesicles. Changes were evidenced by an increased
sensitivity to proteolysis, modiﬁcations in the ﬂuorescence intensity of the probe attached to the C-terminus
and in the proportion of secondary structure elements.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Through their role of linkers between themembrane and the under-
lying cytoskeleton, ezrin/radixin/moesin family of proteins (ERM) orga-
nize complex membrane domains, determine cell shape, participate in
fundamental processes such as adhesion,motility, blebbing, villae orga-
nization, endocytosis or exocytosis and are abundant in subcellular
structures such as rufﬂes, microvilli, apical junction, immunological
synapse, lamellipodia and pseudopodia [1,2]. Invertebrates only express
one essential isoform whereas the three isoforms are present in verte-
brates but with distinct preferential localizations [2]. Ezrin was ﬁrst
isolated in gastric parietal cells, and is mostly present in epithelial
cells, whereas moesin is predominantly found in endothelial cells, and
radixin in hepatocytes [1]. Such partitioning suggests a functional diver-
sity for the three ERM proteins. However, how the three ERM proteins
can play different roles in the cell is still largely unknown. Moesin-
deﬁcient mice do not show any differences with respect to the wild: +33 4 56 52 93 01.
Picart).
rights reserved.type phenotype [3] and exhibit anup-regulation of ezrin and radixin ex-
pression, while radixin-deﬁcient mice exhibit some defects in bile can-
aliculi membranes [4]. This suggests that one ERM can take over
functions speciﬁc to the other members of the ERM family. The only le-
thal mutation was that of ezrin and was linked to ezrin function in gas-
tric epithelial cell membrane organization, as ezrin-deﬁcient mice
showed defects in the gastrointestinal tract and died within 3 weeks
of age [5].
Among the ERM members, ezrin has often been associated to
tumor metastasis [6–9]. Recently, Estecha and co-workers also attrib-
uted a particular role to moesin in the early steps of melanoma tumor
cell invasion of 3D collagen matrices and in transmigration of endo-
thelial cells [10]. The same study showed that ezrin and moesin are
differentially distributed, with a stable cortical actin dome enriched
in moesin and blebs enriched in ezrin. Ezrin and moesin have an im-
portant role in the formation of the immunological synapse [11,12].
Both proteins are present in the distal pole complex but differences
in the phosphorylation and interactions with other cytosolic proteins
have been observed [12]. Moesin is also known to participate to virus
entry into cells. HIV-1 envelope proteins were shown to induce ERM
phosphorylation in lymphocytes. Furthermore, active moesin and to a
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contacts during initial HIV-1 entry [13].
From a structural point of view, ERMproteins are closely relatedwith
73% sequence identity between ezrin andmoesin and 76% between ezrin
and radixin [2]. They all share three important domains: an N-terminal
membrane binding domain (FERM domain), which can bind the mem-
brane via phosphatidylinositol (4,5)-bisphosphate (PIP2), a α-helical
linker region and a C-terminal actin-binding domain (Fig. 1). All ERM
proteins undergo inter-conversion between an inactive and active
conformation. In the inactive (or closed) state, the FERM domain and
the C-terminal domain interact, thus hiding the F-actin binding region
[14]. Activation is believed to open the molecule and unmask the site
of interaction with F-actin. Membrane binding, is an essential step
in ERM activation [15–17] and to their localization at the membrane
[18,19]. Phosphorylation is also thought to be involved in a second step
[16]. However, the molecular mechanism of this activation is not com-
pletely elucidated, so far. Oneof thekey interaction partners at themem-
brane level is PIP2, a lipid largely involved in regulating the organization
and dynamics of the actin cytoskeleton (for review see [20]).
To date, very little is known about moesin afﬁnity for lipids in vitro.
Thus, a primary aim of this work was to quantify moesin binding to
model membrane containing PIP2 and compare it to the results previ-
ously obtained for ezrin [21]. Information about the secondary structure
of ERM protein once bound to a lipid membrane is also very scarce. In
this work, conformational changes of ezrin and moesin after binding
to large unilamellar vesicles (LUV) containing PIP2 were analyzed.
First, we investigatedwhether the environment of ﬂuorophores (intrin-
sic tryptophan and tyrosine residues and extrinsic Alexa 546 probe at-
tached to the C-terminal end of ezrin and moesin) was modiﬁed after
membrane binding. The results were in line with a less compact struc-
ture of the molecule, which was conﬁrmed by limited proteolysisN-term
C-term
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Human ezrin
F3
21
21
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moesin
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Fig. 1. Domain structure of ezrin and moesin. (A) Domain organization and sequence identity
to PIP2 binding. Major phosphorylation site. The F-actin binding domain is located at the
moesin (C). In the absence of crystallographic structures, model structures were obtained fr
blue), F2 (light blue) and F3 (green) are the three lobs of the FERM domain. The central α-experiments. Second, infrared spectroscopy was used to quantitatively
analyze the secondary structure of ezrin and moesin in solution and to
compare it to that of membrane-bound proteins.
2. Materials and methods
2.1. Protein expression and puriﬁcation
Wild-type (WT) ezrin was puriﬁed as previously described [22].
Brieﬂy, GST-tagged ezrin gene was cloned in the pGEX2-T vector and
transformed in Rosetta 2 E. coli bacteria (VWR). Bacteria were routinely
grown in Luria Bertani medium supplemented with 500 mM NaCl,
100 mg/ml ampicillin and 34 mg/ml chloramphenicol. Protein expres-
sion was induced with IPTG (0.5 mM) at a DO600 of 0.6 and bacteria
were harvested by centrifugation after overnight incubation and lysed
by ultrasound in PBS pH 7.4 10 mM EDTA 0.5 mM DTT buffer. After
removal of the bacterial debris, the supernatant was incubated with
glutathione sepharose beads (GE healthcare) for 2 h at 4 °C. Ezrin was
removed from the beads by cleaving the GST moiety with thrombin
(Sigma), in a 20 mM Tris–HCl pH 7.4, 100 mM NaCl, and 0.5 mM DTT
buffer. The protein was then dialysed against a 25 mM Mes pH 6.2,
20 mM NaCl, and 0.5 mM DTT buffer. As at this point several con-
taminant bands being present on SDS-PAGE, the ezrin solution was
further puriﬁed on an anionic exchange chromatography column (GE
Healthcare) in 25 mM Mes pH 6.2 buffer using a NaCl gradient from
20 mM to 1 M. Ezrin was eluted from the column at 70 mM NaCl. One
liter of bacterial culture yielded about 1–2 mg of protein. WT-Moesin
was prepared according to the same procedure, except anionic ex-
change chromatography. Indeed, after GST-tag removal, moesin was
pure and did not require additional puriﬁcation. One liter of bacterial
culture yielded about 3–4 mg of protein.N-term
C-term
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Human moesin
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between human ezrin andmoesin: Positively charged pairs of residues participating
end of the C-terminal domain. (B, C) Ribbon structure of dormant human ezrin (B) and
om protein model portal based on moesin from S. frugipeda structure (2I1JA). F1 (dark
helical region (green) links the FERM domain to the C-terminal domain (red).
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the C-terminal end of ezrin or moesin. The quick change site-directed
mutagenesis kit from Stratagene (Stratagene Europe, Netherlands) was
used for this purpose. Constructions were veriﬁed by sequencing.
All proteins (~1 mg/ml) were stored at 4 °C for 4 weeks in 25 mM
Mes pH 6.2, 70 mM NaCl, 0.5 mM DTT, and 1 mM NaN3 buffer.2.2. Vesicle preparation
Large unilamellar vesicles (LUVs) made of POPC, POPC/PIP2 95/5
(w/w), POPC/PIP3 95/5 (w/w) and POPC/PS 80/20 (w/w) were pre-
pared by drying the appropriate lipid mixture in a Speedvac rotary
evaporator (Eppendorf) and hydrating the lipids with the appropriate
buffer for 1 h 30 at 37 °C. Lipid emulsion was then submitted to 5
freeze–thaw cycles (5 min liquid nitrogen/10 min 37 °C) followed
by extrusion through a stack of two polycarbonate ﬁlters (100 nm
pore diameter, 21 passages) using a miniextruder (Avanti Polar Lipids).
LUVs were stored at 10 mg/ml total lipid concentration for no more
than 2 weeks at 4 °C.
Giant unilamellar vesicles (GUVs) were electroformed following a
procedure adapted from [23]. The appropriate lipid mixtures [PC and
PC/PIP2 (87/13) (w/w)] in chloroform/methanol/water (93.5:6:0.5 v/
v) at 2 mg/ml were spread on ITO-coated plates and dried under vac-
uum for 2 h. An electroformation chamber was then formed using the
ITO plates and a rubber spacer. The chamber was sealed with Vitrex
paste and placed in an incubator at 38 °C. An AC electrical ﬁeld
(10 Hz, 0.2 V) was applied before ﬁlling gently the chamber with a
buffer solution (1.5 ml, pH 7.4, Tris–HCl 2 mM, EGTA 0.5 mM, sucrose
165 mM). The voltage was progressively increased from 0.2 V to 2 V
within 2 h 30 min. The voltage and frequency were subsequently
kept constant at 1 V and 4 Hz for 20 min before switching off the
AC ﬁeld. The as-formed GUVs were kept 1 h in the incubator and
then stored at room temperature and used for confocal imaging the
same day.2.3. Cosedimentation assays
Moesin afﬁnity for phospholipids was determined by sedimenta-
tion assays with sucrose loaded LUVs as previously described for
ezrin [21]. Sucrose-loaded LUVs were prepared in 25 mM Hepes pH
7.2, 200 mM sucrose and 1 mM EDTA buffer. The cosedimentation as-
says were performed in 25 mM Hepes 7.2, 100 mM KCl, and 1 mM
EDTA buffer by varying the concentration of total lipid, while keeping
the percentage of PIP2 in LUVs constant. For these experiments,
moesin concentration was kept constant at 0.4 μM. After incubation
for 15 min at room temperature, the 100 μl samples were centrifuged
at 16,000 ×g for 1 h 30 min at 4 °C. The top 80 μl of each sample was
removed, supplemented with 10 μl 0.2% Triton and considered as su-
pernatant (SN). 10 μl of 0.2% Triton and 60 ml of KCl buffer were used
to resuspend the pellet (P). For experiments with labeled protein, SN
and P intensities were directly read in a 96 well black plate (Nunc)
using a TECAN inﬁnite 1000 ﬂuorimeter with excitation and emission
wavelength set, respectively, at 490 and 521 nm (±5).
Alternatively, for experiments performed using unlabeled ezrin, SN
and P were analyzed on a 10% SDS-PAGE, stained using Coomassie blue.
Quantiﬁcation was achieved using Image J 1.36b (National Institutes of
Health, Bethesda, MD) (the mean density of each band was background
corrected and was checked to be in the linear range of the scanner).
Since 20 μl of the supernatant was counted as pellet and since the super-
natant and pellet resuspension volume were identical, the true pellet in-
tensity was calculated using the formula: IPellet=Imeasured–0.25×ISN,
where IPellet and ISN are the intensity of the pellet and supernatant, re-
spectively. The corresponding percentage of protein bound was calculat-
ed as IPellet×100/(IPellet+ISN).2.4. Quantitative confocal imaging of ezrin and moesin interaction with
GUVs
Confocal microscopy observations of GUVs were carried out on a
spinning disk Rapid confocal imager Ultra View ERS (Perkin Elmer)
mounted on an invertedmicroscope with a 100× oil objective. Fluores-
cent images were analyzed with ImageJ software. The ﬂuorescence in-
tensity was normalized so that the resulting intensity was equal to
0 in the interior of the GUV (where the measured intensity was the
noise signal) and equal to 1 in the external medium (where the mea-
sured intensity is the background intensity of the protein medium).
Adsorption of protein onGUVswas quantiﬁed by averaging the normal-
ized ﬂuorescent intensity at the membrane of the GUV. Results are
average values over typically 30 vesicles. Details of the visualization
protocol and image analysis are given in the supplementary material.
2.5. Fluorescence measurements
Fluorescence emission spectra ofWTezrin andWTmoesin (0.4 μM),
and ﬂuorescence spectra of moesin-Alexa546 and ezrin-Alexa546
(0.4 μM) were recorded in the absence or after addition of increasing
amounts of PIP2-LUVs (1 mg/ml, 1.7 mg/ml and 2.3 mg/ml lipids)
using a TECAN inﬁnite 1000 ﬂuorescence spectrometer. For intrinsic
ﬂuorescence, the excitation wavelength was set at 280±5 nm and
the emission was acquired over 300–400 nm (±5 nm). For Alexa546
ﬂuorescence, the excitation wavelength was set at 540±5 nm and
the emission was acquired over 555–650 nm (±5 nm). Each spectrum
is the average of at least 9 independent measurements.
2.6. Fourier transformed infrared spectroscopy
LUVs at 20 mg/ml total lipids were prepared in a deuterated Hepes–
KCl buffer. Proteins were lyophilized in a Speedvac rotary evaporator
(Eppendorf, France) and resuspended in a deuteratedMES–NaCl buffer.
Lipids and proteins were mixed so that the ﬁnal concentrations were
10 mg/ml and 1 mg/ml (14 μM), respectively for lipids and proteins.
For control experiments, spectra of the LUVs suspension in the same
buffer were recorded. Samples were loaded in an Aquaspec cell and an-
alyzed using a Vertex V70 FTIR apparatus (both from Bruker Optics
GmbH, Germany), continuously purged with dry air. The nominal spec-
tral resolutionwas 4 cm−1. The spectra shownwere corrected from the
contribution of the buffer and of the residual water vapor. Every infra-
red spectrum was representative of at least 3 independent measure-
ments. Deconvolution spectra were obtained with Opus software
(Bruker) after determination of the peak position using the second de-
rivative of the spectra.
2.7. Limited proteolysis experiments
Ezrin or moesin (0.8 μM) were incubated in the Hepes–KCl buffer
with 2 mg/ml PIP2-LUVs or with the appropriate volume of buffer for
15 min. Note that the concentrations of protein and LUVs were cho-
sen such that the % of protein bound to LUVs was maximum
(~80%). Proteolysis was initiated by the addition of 15 μM (respec-
tively 1.5 μM) chymotrypsin to samples containing moesin (respec-
tively ezrin) and followed over a 90 min time period at room
temperature (22 °C). The reaction was stopped at speciﬁed time
laps by the addition of 1 mM protease inhibitor (phenylemethane
sulfonyl ﬂuoride). 20 μl of each sample was run on a 10% SDS-Page
electrophoresis gel and stained with Coomassie blue. Quantiﬁcation
of the gels was done using ImageJ software. The percentage of intact
(full length) protein at time t was calculated as the ratio between
the intensity of the full length band (69 kDa for ezrin, 68 kDa
for moesin) at time t over its value immediately after addition of
chymotrypsin.
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3.1. Comparative study of the binding of ezrin and moesin to PIP2
Fluorescence confocal imaging was ﬁrst used to compare the bind-
ing of ezrin and moesin on the biomimetic membrane of GUVs that
contain PIP2. Once immersed in a protein suspension comprising ﬂuo-
rescent proteins in large excess with respect to PIP2, we found that
almost all PIP2-GUVs displayed a ﬂuorescent membrane, whereas
PC-GUVs showed no adsorption of the ﬂuorescent protein at the mem-
brane. In order to assess the binding afﬁnity ofWT and ﬂuorescent pro-
teins for the PIP2-GUV membrane, experiments were performed by
plunging the PIP2-GUVs in various protein mixtures comprising one
ﬂuorescent protein (either ezrin-Alexa488 or moesin-Alexa488) at a
ﬁxed concentration of 2 μM and various concentrations of WT proteins.
Typical confocal images are reported in Fig. 2A–D for mixtures of ﬂuo-
rescent moesin and WT ezrin prepared at increasing concentrations of
WT ezrin. We observed a decrease in the ﬂuorescence intensity at theWT Protein concentration (µM)
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Fig. 2. Confocal microscopy observations of the interaction of ezrin and moesin with
PIP2-GUVs. (A–D) Imaging of moesin-Alexa488 binding to PIP2-GUVs. Confocal micros-
copy of GUVs (equatorial section) in contact with mixtures of 2 μM moesin-Alexa488
and increasing amounts of WT ezrin: (A) 0 μM (B), 1.5 μM, (C) 3.1 μM and (D) 4.6 μM.
(E). Fluorescence intensity at the GUV membrane as a function of the WT ezrin, for 3 dif-
ferent protein mixtures: (○) WT ezrin/ezrin-Alexa488, (□) WT ezrin/moesin-Alexa488,
and (▽) WTmoesin/moesin-Alexa488). Inset: same data plotted as a function of the frac-
tion of ﬂuorescent proteins in the protein mixture. The line is a linear ﬁt of the data.membrane when the concentration ofWT protein increased. To quanti-
fy this effect, wemeasured the normalized ﬂuorescence intensity at the
membrane as a function of the concentration of WT proteins (Fig. 2E).
Data obtained in the experimental conditions (WT and ﬂuorescent
ezrin, WT and ﬂuorescent moesin, and WT ezrin and ﬂuorescent
moesin) all collapsed on a unique curve. The ﬂuorescence intensities
at the membrane continuously decreased in all conditions. This is pre-
cisely what is expected if both ﬂuorescent andWT protein interact sim-
ilarly with themembrane. Interestingly, we found that the ﬂuorescence
intensity was proportional to the fraction of ﬂuorescent protein in the
protein mixture, as shown in the inset of Fig. 2E. This demonstrates
that the non‐ﬂuorescent and the ﬂuorescent proteins have equivalent
binding afﬁnity for the membrane of PIP2-GUVs.
In order to compare the afﬁnities between the proteins and PIP2,
we used co-sedimentation assays to measure the dissociation con-
stant (Kd) between the protein and PIP2-LUVs. We recently deter-
mined the Kd value for ezrin interactions with PIP2-LUVs [21]. Here,
various concentrations of sucrose loaded PIP2-LUVs were incubated
in a buffer containing WT moesin at a ﬁxed concentration (0.4 μM).
Centrifugation allows the vesicle-bound moesin (in the pellet) to be
separated from the soluble protein (in the supernatant). Typical im-
ages of SDS-PAGE gels representing the pellets and the supernatants
are shown in Fig. 3A for increasing lipid concentrations. In Fig. 3B
the percentage of moesin bound is represented as a function of the ac-
cessible acidic lipid concentration. We found that the percentage of
bound moesin increased with the increasing amount of PIP2-LUVs.
The ﬁt of the experimental data leads to a dissociation constant
Kd=(5.6±0.7 μM), a numerical value equal within experimental er-
rors to that previously determined for ezrin in the same conditions[acidic phospholipid] accessible (M) or [PC] (M)
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Fig. 3. Moesin binding to LUVs of different composition by cosedimentation assay:
(A). SDS-PAGE gel of moesin (0.4 μM) incubated with increasing amounts of POPC/PIP2
LUVs (95/5) after separation of pellet (P) and supernatant (SN). (B) Percentage of WT
moesin bound to LUVs as a function of the concentration of acidic lipid: (○) (PC/PIP2,
95/5), (●) (PC/PIP3, 95/5), X axis is the accessible concentration in PIP2, (respectively
PIP3) [PIP2]acc, calculated assuming that the PIP2 molecules are equally distributed in the
two membrane leaﬂets and that only the molecules in the outer leaﬂet are accessible to
the proteins; (□) (PC/PS, 80/20), X axis is the accessible concentration in PS, [PS]acc;
(▽), PC, X axis is the accessible lipid concentration. The curves are the least squares ﬁts
of the data, which yield the value of the afﬁnity constant Kd (points are means±SD of 3
independent experiments).
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performed with LUVs composed of POPC or of a mixture of POPC
and PS (80/20), a negatively charged lipid. Results are also reported
on Fig. 3B. Moesin showed no afﬁnity for pure POPC LUVs (Fig. 3, tri-
angles) and a very low afﬁnity, of electrostatic origin, for PS-LUVs
(Fig. 3, squares). But data are too scattered in this case to determine
a dissociation constant. Moesin also bound to phosphoinositol
(3,4,5) triphosphate (PIP3) with equal afﬁnity (within the experimen-
tal error) to that of PIP2, i.e. 6.2±1.3 μM. Our results conﬁrm quanti-
tatively that moesin, similar to ezrin [21], has binding speciﬁcity for
PIP2 and PIP3 over PS. Of note, the binding of ﬂuorescently labeled
moesin, moesin-Alexa488 (Fig S1 in the Supporting Material) and
moesin-Alexa546 (not shown) to PIP2-LUVs, as measured by the
cosedimentation assay, was also quantiﬁed by spectroﬂuorimetry. By
this method, we found that moesin-Alexa488 binds to PIP2-LUVs with
a dissociation constant Kd=(10.7±1.8 μM), and moesin-Alexa546
with a Kd=4.5±1.1 μM a value comparable to that obtained with
WT moesin. Thus, the cystein mutation and the labeling with the
Alexa dye did not induce a major modiﬁcation in moesin binding to
PIP2-LUVs.
Furthermore, co-sedimentation experiments were performed using
protein mixtures with increasing moesin/ezrin ratio. The fraction of
moesin bound to PIP2-LUVs was equal to that of moesin in the initialFig. 4. Quenching of tryptophan ﬂuorescence emission after protein binding to PIP2-LUVs. F
increasing amounts of PIP2-LUVs. The protein concentration was ﬁxed at 0.4 μM and the LU
sible PIP2. (A′–B′) Quenching of tryptophan after addition of increasing concentrations of P
accessible PIP2 concentration, or after addition of the equivalent amount of POPC-LUVs or
bars are S.D. of at 3 independent measurements.mixture (Fig S2 in the Supporting Material), which conﬁrmed the sim-
ilar afﬁnity of ezrin and moesin for PIP2.
3.2. Conformational changes of ezrin and moesin after binding
to PIP2-LUVs
Fluorescence and FTIR spectroscopy were used to investigate the ef-
fect of PIP2-binding on the internal structure of the proteins and on the
ﬂuorescence of intrinsic ﬂuorophore residues and of the Alexa dye.
Fig. 4 shows the evolution of the ﬂuorescence emission spectra of WT
ezrin (A) and moesin (B) upon addition of increasing concentrations
of PIP2-LUVs. We did not detect any shift in the position of the maxi-
mum emission wavelength, but we recorded a systematic decrease in
the ﬂuorescence emission intensity. To discriminate between an effect
due to scattering phenomena after addition of vesicles and a change
in the environment of tryptophan residues, the quenching (at the max-
imum emission wavelength) was also measured after addition of equal
amounts of LUVs composed uniquely of POPC with which the proteins
do not interact. We found that the quenching of intrinsic ﬂuorescence
in ezrin (Fig. 4A′) or moesin (Fig. 4B′) was systematically and signiﬁ-
cantly higher after the addition of PIP2-LUVs than after the addition of
POPC-LUVs. The low quenching in the presence of POPC-LUVs was
indeed comparable to the quenching measured after the addition ofluorescence emission spectra of ezrin (A) and moesin (B) in the absence or presence of
V concentration varied between 1 and 2.3 mg/ml, corresponding to 23 to 56 μM acces-
IP2-LUVs, corresponding to 23 μM (black), 40 μM (light grey) and 53 μM (dark grey)
of the equivalent volume of buffer to a suspension of ezrin (A′) or moesin (B′). Error
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binding on the environment intrinsic ﬂuorophores.
In addition, we investigated whether the ﬂuorescence of the Alexa
dye, which was grafted at the C-terminus of the proteins, was affected
by binding of the proteins to PIP2-LUVs. The ﬂuorophore is located at
the C-terminal end of the proteins that is not expected to interact
with the lipid membrane. Thus, its ﬂuorescence is not expected to
be directly affected by membrane binding. Instead, it should be sensi-
tive to a conformational change of the protein. For both ezrin and
moesin, we recorded a decrease of the ﬂuorescence of Alexa546
after binding to PIP2-LUVs (Fig. 5A and B). The percentage of
quenching as a function of the accessible PIP2 concentration in LUVs
followed a sigmoidal shape (Fig. 5C), which can be ﬁtted using a
ﬁrst order ligand binding model. This yielded a dissociation constant
Kd of (6.6±1.8 μM) for ezrin and of (3.2±0.7 μM) for moesin. These
values were comparable to the ones obtained by co-sedimentation
assays.
In order to assess whether ﬂuorophore quenching was in favor of a
looser structure of the proteins, which would support the hypothesis
of molecule opening after membrane binding, ezrin and moesin were
submitted to the action of chymotrypsin. The action of chymotrypsin
was studied on proteins in the absence of PIP2-LUVs, as well as forFig. 5. Quenching of Alexa546-label ﬂuorescence emission after protein binding to
PIP2-LUVs. Typical ﬂuorescence emission spectra of ezrin (A) and moesin (B) in the ab-
sence (solid) or presence (long dash) of 1 mg/ml PIP2-LUVs. C. Quenching of ezrin (●)
and moesin (■) ﬂuorescence after addition of increasing amounts of PIP2-LUVs as a
function of accessible PIP2 concentration. The symbols are experimental data and the
lines are best ﬁts using a ﬁrst order ligand binding model. Error bars are S.D. of at 3 in-
dependent measurements.proteins interacting with PIP2-LUVs. The proteolysis reaction was
followed by SDS-PAGE (Fig. 6). The intensity of the band corresponding
to full length moesin (68 kDa) progressively diminished with time and
completely disappeared after 60 min (Fig. 6A). Moesin digestion by
chymotrypsin was faster when the protein was bound to the PIP2-LUVs
membrane. In this case, the protein was completely degraded after
10 min (Fig. 6B). For ezrin, the same amount of chymotrypsin (15 μM)
completely degraded the protein in less than 5 min (data not shown),
meaning that ezrinwasmuchmore sensitive to proteolysis thanmoesin.
The chymotrypsin concentration was thus reduced from 15 to 1.5 μM.
In these conditions, ezrin was degraded in ~30 min in the absence of
vesicles (Fig. 6D) and in ~5 to 10 min in the presence of PIP2-LUVs
(Fig. 6E). The main degradation band for both proteins was situated
between 38 and 43 kDa and can be attributed to a fragment roughly
corresponding to the FERM domain [15,24]. The time evolution of the
intensity of the full length protein band is plotted in Fig 6C and F, for
moesin and ezrin respectively. Considering that in the initial step (over
the ﬁrst 5–10 min of incubation), the concentration of full length pro-
tein linearly decreased with time, the degradation rate of moesin
was estimated at 0.11 mg moesin/min/nmol chymotrypsin in the
absence of vesicles and at 0.19 mg moesin/min/nmol chymotrypsin
in their presence. For ezrin, the degradation rate was estimated at
1.71 mg ezrin/min/nmol chymotrypsin in the absence of vesicles and
at 6.19 mg ezrin/min/nmol chymotrypsin in the presence of PIP2-LUVs.
Of note, as described in the Materials and methods section, the puriﬁ-
cation protocol of ezrin requires an additional puriﬁcation step using
an anionic exchange chromatography, as degradation contaminants
are present after separation of the GST-tagged protein on glutathione
beads. This is in line with the higher sensitivity of ezrin to proteolysis
[25]. Altogether, these results indicate that both moesin and ezrin be-
come more accessible to the action of chymotrypsin after membrane
binding.
Finally, we compared the secondary structure of ezrin and moesin
before and after binding to lipid membrane containing PIP2. Fig. 7A
shows infrared spectra of moesin and ezrin in the amide I region
(1600–1700 cm−1) in the absence of lipids. Despite high primary se-
quence homology, the infrared spectra of moesin and ezrin presented
noticeable differences. In particular, the maximum position of the
amide I band was shifted from 1638 cm−1 for moesin to 1646 cm−1
for ezrin. Second derivatives of the spectra allowed us to locate the
peak positions corresponding to four major types of secondary struc-
tures (Fig. 7B and C), which are typically observed for proteins
[26–28]: α-helix, intramolecular β-sheets (with two contributions at
low and high wavenumbers), random coils and intermolecular
β-sheets. From the best ﬁts of ezrin and moesin spectra (Fig. 7B and
C), the percentages of each type of secondary structure were calculated
(Table 1).α-Helices represented ~42% of ezrin and 46% of the secondary
structure of moesin, respectively. An important antiparallel β-sheet
contribution was also identiﬁed at ~1626 cm−1 together with the
corresponding high wavenumber contribution at ~1678 cm−1. These
accounted for 30% of ezrin and for 27% of moesin structural elements.
A third contribution from coil structures was also present and
accounted for 25% of ezrin and 27% of moesin secondary structure. Of
note, ezrin spectrum, and to a much lower extent moesin spectrum,
showed a very small shoulder at ~1610 cm−1, which can be attributed
to the presence of intermolecular β-sheets.
The presence of PIP2-LUVs induced noticeable changes in the in-
frared spectra of both proteins (Fig. 8A and B). First, for both proteins,
lipid binding resulted in an apparent shift of maximum absorption of
the amide I band toward lower wavenumbers (see arrows in Fig. 8A
and B) together with a decrease in the contributions in theα-helix re-
gion (1650–1655 cm−1). Deconvolution of the spectra from Fig. 8A
and B conﬁrmed these observations (Fig. 8C and Table 1). The content
of α-helices decreased from 42 to 36% for ezrin and from 46% to 35%
for moesin in the presence of PIP2-LUVs. Conversely, the random coil
contribution increased from 25 to 32% for ezrin and from 27% to 34%
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Fig. 6. Digestion of moesin and ezrin by chymotrypsin. Moesin (A–C) or ezrin (D–F) degradation in the absence (A, D) or presence of PIP2-LUVs (B, E). Evolution of the intensity of
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the contribution at very low wavenumbers was barely visible in the
presence of PIP2-LUVs. This indicated that intermolecular β-sheet in-
teractions were reversible.
All together, the infrared spectra prove that conformational changes
occurred after binding of ezrin and moesin to PIP2-LUVs, with a de-
crease of α-helices and a concomitant increase of random coils.
4. Discussion
4.1. Moesin and ezrin show similar afﬁnities for PIP2
Moesin and ezrin, two members of the ERM family of proteins,
share a similar structure and a high primary sequence homology
[1,2]. However, recent reports point out differential roles in several
physiological and pathological situations such as cell metastasis [10]
or the formation of the immunological synapse [11,12]. A number of
biophysical studies have shed some light on ezrin interaction with
membranes. We have previously shown that ezrin has a moderatebut speciﬁc afﬁnity for PIP2-containing LUVs (dissociation constant
of the order of 5 μM) [21]. Ezrin interacts with a 1:1 stoichiometry
with PIP2 incorporated in the membrane of LUVs and the interaction
was found to be cooperative for PIP2 inserted in solid supported
bilayers [29]. Ezrin also showed the capacity of forming multimers
in the presence of PIP2 added in solution [24]. It formed ezrin-rich do-
mains on PIP2-containing supported lipid bilayers [29] and induced
PIP2-clustering on giant unilamellar vesicles (GUVs) [23]. These ex-
periments on synthetic membranes suggested that ezrin could mod-
ulate PIP2 distribution at the plasma membrane. Moesin recruitment
at the membrane and its subsequent phosphorylation during Dro-
sophila development also require PIP2 binding [30]. In that study,
co-sedimentation experiments revealed that moesin interacted with
PIP2-containing liposomes. However, to our knowledge, there was
no quantitative analysis of moesin binding to PIP2, nor comparative
data on ezrin and moesin structure in solution versus membrane-
bound. Furthermore, as literature suggests that ezrin and moesin
show some functional disparities, despite very similar structures, there
was a call for comparing their behavior upon membrane binding.
Fig. 7. Comparative analysis of moesin and ezrin secondary structure by FTIR spectrosco-
py. (A). Infrared spectra of ezrin (black line) and moesin (gray line) in the amide I region.
(A′). Amide I band with ﬁtted component peaks for ezrin (B) and for moesin (C). Experi-
mental spectrum (thick black line), sum of ﬁtted components (gray line),α-helices (short
dash), antiparallel β sheets (thin black line), random coils (long dash), intermolecular β
sheets (dotted line).
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Kd, for moesin and lipid membranes made of a mixture of POPC and
PIP2 (95/5 w/w). Co-sedimentation assays using WT and ﬂuorescent
moesin, yield comparable numerical values for Kd with an average
Kd=(6.56±3.8 μM). Notably, the Kd value found by analysis the ﬂuo-
rescence of the ﬂuorescent tag of moesin or ezrin gave a similar value.
These values were moreover comparable to those previously deter-
mined for ezrin [21]. They are also in the same order of magnitude
as that of other membrane associated proteins such as a fragment
from N-WASP [31] or talin [32]. Moreover both proteins moesin and
ezrin [21] interacted with PIP3 with similar afﬁnity, but bound toPS-containing vesicles only marginally. These measurements were
complemented by quantitative confocal imaging on the interaction
of ﬂuorescent proteins with the lipid membrane of GUVs made of
PC/PIP2 (87/13w/w). By usingmixtures of ezrin andmoesin in different
proportions, we demonstrated by quantitative confocal image analysis
of PIP2-GUVs, the absence of preferential binding of one of the two pro-
teins on PIP2-containing membranes. The fact that both proteins bind
similarly is a prerequisite to account for the fact that ezrin could take
over the function of moesin in moesin-deﬁcient mice [3]. In cellulo,
some differences in moesin and ezrin distribution have been observed.
For instance, a different behavior between moesin and ezrin has been
found during the formation of the immunological synapse [11]. In
tumor cells, moesin was present at the dorsal surface of migrating
cells whereas ezrin was localized in blebs [10]. We suggest that these
differences in protein distribution cannot be attributed to preferential
afﬁnity for PIP2. Other protein partners, such as transmembrane recep-
tors that can interact with ezrin or moesin, or other cytoplasmic pro-
teins may play a role in the speciﬁc location observed in cellulo.
4.2. Conformational changes of ezrin and moesin after membrane
binding
It is generally accepted that all ERMs exist in an apparently dor-
mant, closed conformation and that the release of the C-terminal
domain from the FERM domain is necessary for their full activation
and for their function as membrane-cytoskeleton linkers. Membrane
binding plays a crucial part in this activation process. However, the
mechanisms and the structural elements involved are not completely
characterized.
Tryptophan residues embedded in protein structures are known
to be sensitive to the polarity of the surrounding molecules. Any
change in the protein conformation that affects the surroundings of
these residues is expected to be reﬂected by changes in the intrinsic
ﬂuorescence of these residues. This change may be visible on the ﬂuo-
rescence intensity and/or in the wavelength corresponding to the
maximum of ﬂuorescence emission, depending on whether the tryp-
tophan residues are exposed or buried due to the protein conforma-
tional changes. Ezrin and moesin possess 7 tryptophan residues, of
which 6 are located in the FERM domain and one is located in the
linker region. Upon interaction with PIP2-LUVs, no shift in the trypto-
phan emission spectrum was noted, but rather a marked decrease in
its ﬂuorescence (Fig. 4), in line with previous observations on ezrin
interaction with soluble PIP2 [24]. Although an effect of PIP2 binding
on the protein ﬂuorophores cannot be completely excluded, previous
measurements showed that soluble PIP2 induced a more important
quenching after binding to the full length ezrin than to the isolated
FERM domain [24]. So, we may rather attribute this change to a struc-
tural modiﬁcation. This quenching can be interpreted as due to tryp-
tophan residues becoming more accessible to water molecules.
Interestingly, theﬂuorescence emission of the Alexa546ﬂuorophore
grafted at the C-terminus of the ezrin and moesin was also affected by
binding to PIP2 membranes (Fig. 5). A control experiment revealed
that the ﬂuorescence of Alexa 546 decreased with solvent polarity
(data not shown). As the C-terminal region of the proteins does not di-
rectly interact with the membrane, we interpreted the decrease in the
intensity of the Alexa546 as a consequence of the conformational
change: upon opening of the protein, the C-terminal domain became
more accessible to water molecules. Limited proteolysis experiments
(Fig. 6) further support the hypothesis of molecule opening. Indeed,
both ezrin and moesin were more rapidly degraded by chymotrypsin
after binding to PIP2-LUVs, in linewith an increased accessibility of pro-
teolysis sites due to this conformational change. As previously described
[15,24]. The main degradation band of both proteins corresponded to
the FERM domain, which indicated that the chymotrypsin sensitive re-
gionswere outside this domain. In the absence of lipids, ezrinwasmuch
more sensitive to the action of the protease than moesin. This
Fig. 8. Secondary structure modiﬁcations of moesin and ezrin in presence of PIP2-LUVs. Infrared spectra of ezrin (A) and moesin (B) in the absence (solid line) or presence of PIP2-LUVs
(dashed line) in the amide I region. (C) Relative contribution to the peak area of the main types of secondary structures obtained by deconvolution of the spectra shown in A and B.
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the linker and C-terminal domain of ezrin which are preferential cleav-
age site of chymotrypsin, while only 3 such residues are present in
moesin primary structure. Our results are in line with those of
Shcherbina et al. [25], who found an increasing sensitivity of ezrin for
the protease calpain as compared to moesin.
Although the crystallographic structure of the full length moesin
of S. frugiperda has been solved in 2007, there is, to our knowledge,Table 1
Results of the deconvolution of the FTIR spectra of ezrin and moesin at 14 μM in solution as
of the band, as determined by deconvolution, is given as well as the % relative to the integr
Secondary structure Ezrin
– PIP
α Helix 1653 cm−1 16
42% 36
Random coil 1637 cm−1 16
25% 32
Antiparallel intramolecular β sheet 1627/1678 cm−1 16
30% 31
Intermolecular β sheet 1607 cm−1 16
3% 1%only few quantitative data available on the secondary structure of
full length ezrin [33] and none available for moesin in solution.
Here, using infrared spectroscopy, we obtained quantitative informa-
tion on the different types of secondary structures present in the full
length proteins (Fig. 7). As could be anticipated from the crystallo-
graphic structure (Fig. 1), the most prominent type of secondary
structure was α-helices, which represented ~42% and 46% of ezrin
and moesin. This was followed by two important contributions ofwell as in interaction with PIP2-LUVs (at 10 mg/ml). The wavenumber of the maximum
al of the total amide I band.
Moesin
2-LUVs – PIP2-LUVs
53 cm−1 1653 cm−1 1652 cm−1
% 46% 35%
39 cm−1 1639 cm−1 1639 cm−1
% 27% 34%
26/1671 cm−1 1626 /1676 cm−1 1627 /1671 cm−1
% 27% 30%
10 cm−1 1612 cm−1 1609 cm−1
1% 1%
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fraction of α-helices reported in the X-ray crystallographic structure
of insect moesin [34] was of 49% for α-helices, 37% for random coils
and 13% for β-sheets. Thus, our experimental data agree with these,
except that we systematically ﬁnd, for moesin as well as for ezrin, a
higher fraction of β‐sheets. Of note, a recent study by circular dichro-
ism reported for full length ezrin values of 71% α-helix, which were
above the X-ray predictions, 18% for random coils and only of
4% β‐sheets [33], which were both below the X-ray predictions.
Two bands visible on the infrared spectrum of ezrin at 1607 and
1690 cm−1, but to a lesser extent on the spectrum of moesin, can
be attributed to the presence of intermolecular β-sheets [26]. The
formation of these intermolecular H bonds can be attributed either
to the formation of aggregates at high protein concentration or to
the formation of multimers. These bands disappear after ezrin bind-
ing to LUVs indicating that the intermolecular H bond formation was
reversible and thus supporting the formation of multimeric species
rather than inert aggregates. Of note, due to their high curvature,
LUVs, unlike supported lipid bilayers or GUVs, seem not to promote
ezrin clustering [21].
The most prominent change observed after binding to PIP2-LUVs
was a decrease of the proportion of α-helices in favour of random
coil structures (Fig. 8 and Table 1).Which protein domain ismore like-
ly to be affected? A ﬁrst tempting hypothesis is the α-helical linker
that may unwind after molecule opening. However, the isolated linker
domain of radixinwas described as a stableα‐helical rod of an unusual
length [35]. Conformational changes may also take place in the FERM
domain, which is directly affected by membrane binding. Comparison
of crystallographic data on the FERM domain in the absence [36] or
presence of the C-terminal domain [14] or of IP3 [37] showed essen-
tially the same organization of the three subdomains. Important dis-
placements were observed locally [36,37], but not with an obvious
loss of secondary structure elements. However, it is interesting to
note that Kitano et al. [38] identiﬁed a “chameleon” region at the
end of the radixin FERM domain. In fact, this region had the capacity
to form either β-sheets or α-helices, depending on the environment.
We can also hypothesize that the loss of α-helical structures after
membrane binding occurred in the C-terminal domain once interac-
tions with the FERM domain are disrupted. Further experiments are
however needed to investigate whether this structural change is suf-
ﬁcient to completely release the FERM domain from the C-terminal
and allow interaction with actin ﬁlaments via amino acids located at
the end of the C-term domain [39]. It remains also to be assessed
whether phosphorylation on residue T559/T567 plays a major role
in ERM activation, or whether, as recently suggested, regulation via
PIP2 binding could be sufﬁcient to control moesin distribution and ac-
tivity. In this case, phosphorylation on residue T559 would not be es-
sential in the opening process [40].
To sum up, the secondary structures of moesin and ezrin showed
similarities and both proteins were found to bind with similar afﬁni-
ties to PIP2-LUVs and PIP2-GUVs. Tryptophan and Alexa546 ﬂuores-
cence quenching points out to a change in the environment of the
ﬂuorophores after membrane binding. Ezrin and moesin bound to
PIP2-LUVs were more sensitive to proteolysis, which indicates that
the two ERM proteins adopt a looser structure after binding to a
lipid membrane. This is consistent with the infrared spectra of pro-
teins interacting with PIP2-LUVs, which showed a decrease in the
α-helical content together with an increase in the random coil pro-
portion, as compared to proteins in solution.
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